DRG prospective, 'all payor systems,' financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs

E. Munoz, L. Barrau, J. Goldstein, Teresa Benacquista, K. Mulloy, L. Wise

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Previous work by our group had suggested that some pulmonary medicine diagnosis-related group (DRGs) did not adequately compensate for patients with multiple complications and comorbidities. Congress has recommended no major changes to pulmonary medicine DRGs along these lines. The purpose of this study was to analyze resource comsumption in any of the seven noncomplicating conditions (CC), stratified pulmonary medicine DRGs using the new DRG prospective 'all payor system' in effect at our hospital. Analysis of 858 pulmonary medicine patients by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in these non-CC stratified pulmonary medicine DRGs for a three-year period demonstrated that patients with more CCs per DRG for each payor generated higher total hospital costs, a longer hospital lengh of stay, a greater percentage of procedures per patient, financial risk under DRG payment, more outliers, and a higher mortality, compared to patients in these same DRGs with fewer CCs. Both hospital length of stay and total cost per patient (adjusted for DRG weight index) increased with CCs. Financial risk per patient under DRGs also increased as CCs accumulated. These findings suggest that new prospective DRG 'all payor systems' may be inequitable to certain groups of patients or types of hospitals vis-a-vis the non-CC stratified pulmonary medicine DRGs. Many pulmonary medicine DRGs should be stratified by the numbers and types of CCs to more equitably reimburse hospitals under DRG all-payor systems.

Original languageEnglish (US)
Pages (from-to)855-861
Number of pages7
JournalChest
Volume94
Issue number4
StatePublished - 1988

Fingerprint

Pulmonary Medicine
Hospital Costs
Diagnosis-Related Groups
Length of Stay
Blue Cross Blue Shield Insurance Plans
Medicaid
Medicare
Insurance

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

DRG prospective, 'all payor systems,' financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs. / Munoz, E.; Barrau, L.; Goldstein, J.; Benacquista, Teresa; Mulloy, K.; Wise, L.

In: Chest, Vol. 94, No. 4, 1988, p. 855-861.

Research output: Contribution to journalArticle

Munoz, E, Barrau, L, Goldstein, J, Benacquista, T, Mulloy, K & Wise, L 1988, 'DRG prospective, 'all payor systems,' financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs', Chest, vol. 94, no. 4, pp. 855-861.
Munoz, E. ; Barrau, L. ; Goldstein, J. ; Benacquista, Teresa ; Mulloy, K. ; Wise, L. / DRG prospective, 'all payor systems,' financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs. In: Chest. 1988 ; Vol. 94, No. 4. pp. 855-861.
@article{70bb011d611142a880f28fa09cbadd2a,
title = "DRG prospective, 'all payor systems,' financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs",
abstract = "Previous work by our group had suggested that some pulmonary medicine diagnosis-related group (DRGs) did not adequately compensate for patients with multiple complications and comorbidities. Congress has recommended no major changes to pulmonary medicine DRGs along these lines. The purpose of this study was to analyze resource comsumption in any of the seven noncomplicating conditions (CC), stratified pulmonary medicine DRGs using the new DRG prospective 'all payor system' in effect at our hospital. Analysis of 858 pulmonary medicine patients by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in these non-CC stratified pulmonary medicine DRGs for a three-year period demonstrated that patients with more CCs per DRG for each payor generated higher total hospital costs, a longer hospital lengh of stay, a greater percentage of procedures per patient, financial risk under DRG payment, more outliers, and a higher mortality, compared to patients in these same DRGs with fewer CCs. Both hospital length of stay and total cost per patient (adjusted for DRG weight index) increased with CCs. Financial risk per patient under DRGs also increased as CCs accumulated. These findings suggest that new prospective DRG 'all payor systems' may be inequitable to certain groups of patients or types of hospitals vis-a-vis the non-CC stratified pulmonary medicine DRGs. Many pulmonary medicine DRGs should be stratified by the numbers and types of CCs to more equitably reimburse hospitals under DRG all-payor systems.",
author = "E. Munoz and L. Barrau and J. Goldstein and Teresa Benacquista and K. Mulloy and L. Wise",
year = "1988",
language = "English (US)",
volume = "94",
pages = "855--861",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - DRG prospective, 'all payor systems,' financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs

AU - Munoz, E.

AU - Barrau, L.

AU - Goldstein, J.

AU - Benacquista, Teresa

AU - Mulloy, K.

AU - Wise, L.

PY - 1988

Y1 - 1988

N2 - Previous work by our group had suggested that some pulmonary medicine diagnosis-related group (DRGs) did not adequately compensate for patients with multiple complications and comorbidities. Congress has recommended no major changes to pulmonary medicine DRGs along these lines. The purpose of this study was to analyze resource comsumption in any of the seven noncomplicating conditions (CC), stratified pulmonary medicine DRGs using the new DRG prospective 'all payor system' in effect at our hospital. Analysis of 858 pulmonary medicine patients by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in these non-CC stratified pulmonary medicine DRGs for a three-year period demonstrated that patients with more CCs per DRG for each payor generated higher total hospital costs, a longer hospital lengh of stay, a greater percentage of procedures per patient, financial risk under DRG payment, more outliers, and a higher mortality, compared to patients in these same DRGs with fewer CCs. Both hospital length of stay and total cost per patient (adjusted for DRG weight index) increased with CCs. Financial risk per patient under DRGs also increased as CCs accumulated. These findings suggest that new prospective DRG 'all payor systems' may be inequitable to certain groups of patients or types of hospitals vis-a-vis the non-CC stratified pulmonary medicine DRGs. Many pulmonary medicine DRGs should be stratified by the numbers and types of CCs to more equitably reimburse hospitals under DRG all-payor systems.

AB - Previous work by our group had suggested that some pulmonary medicine diagnosis-related group (DRGs) did not adequately compensate for patients with multiple complications and comorbidities. Congress has recommended no major changes to pulmonary medicine DRGs along these lines. The purpose of this study was to analyze resource comsumption in any of the seven noncomplicating conditions (CC), stratified pulmonary medicine DRGs using the new DRG prospective 'all payor system' in effect at our hospital. Analysis of 858 pulmonary medicine patients by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in these non-CC stratified pulmonary medicine DRGs for a three-year period demonstrated that patients with more CCs per DRG for each payor generated higher total hospital costs, a longer hospital lengh of stay, a greater percentage of procedures per patient, financial risk under DRG payment, more outliers, and a higher mortality, compared to patients in these same DRGs with fewer CCs. Both hospital length of stay and total cost per patient (adjusted for DRG weight index) increased with CCs. Financial risk per patient under DRGs also increased as CCs accumulated. These findings suggest that new prospective DRG 'all payor systems' may be inequitable to certain groups of patients or types of hospitals vis-a-vis the non-CC stratified pulmonary medicine DRGs. Many pulmonary medicine DRGs should be stratified by the numbers and types of CCs to more equitably reimburse hospitals under DRG all-payor systems.

UR - http://www.scopus.com/inward/record.url?scp=0023814462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023814462&partnerID=8YFLogxK

M3 - Article

C2 - 3139375

AN - SCOPUS:0023814462

VL - 94

SP - 855

EP - 861

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -